Literature DB >> 26948710

The Dutch patients' perspective on oculopharyngeal muscular dystrophy: A questionnaire study on fatigue, pain and impairments.

Barbara M van der Sluijs1, Hans Knoop2, Gijs Bleijenberg2, Baziel G M van Engelen1, Nicol C Voermans3.   

Abstract

Research on oculopharyngeal muscular dystrophy focuses mainly on genetic and pathophysiological aspects. Clinically, oculopharyngeal muscular dystrophy is often considered as a disease with a relatively mild initial disease course with no or only mild functional disabilities. However the occurrence of fatigue, pain and functional impairments other than dysphagia has never been studied systematically. The aim of this study is therefore to assess the prevalence of fatigue, pain, and functional limitations, and the social participation and psychological well-being of oculopharyngeal muscular dystrophy patients. We performed a questionnaire study on fatigue, pain, functional impairments, social participation and psychological distress in 35 genetically confirmed oculopharyngeal muscular dystrophy patients with an average disease duration of 11.6 years. We showed that 19 (54%) of the patients experienced severe fatigue and also 19 (54%) experienced pain. Limitations in daily life activities and social participation were detected in 33 (94%) of the patients. Many patients reported pelvic girdle weakness and limitations in ambulation. Fatigue severity was related to functional impairments, while pain and disease duration were not. Psychological distress was not different from healthy adults. In conclusion, fatigue and pain are present among approximately half of the patients, and almost all patients are impaired in daily life activities, social participation and ambulation. These data should be taken into account in symptomatic management of oculopharyngeal muscular dystrophy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fatigue; Functional impairments; OPMD; Pain

Mesh:

Year:  2016        PMID: 26948710     DOI: 10.1016/j.nmd.2015.12.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument.

Authors:  Sarah Youssof; Carol Romero-Clark; Teddy Warner; Emily Plowman
Journal:  Muscle Nerve       Date:  2017-02-12       Impact factor: 3.217

2.  Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy.

Authors:  Christophe Béroud; Sabrina Sacconi; Benoît Sanson; Caroline Stalens; Céline Guien; Luisa Villa; Catherine Eng; Sitraka Rabarimeriarijaona; Rafaëlle Bernard; Pascal Cintas; Guilhem Solé; Vincent Tiffreau; Andoni Echaniz-Laguna; Armelle Magot; Raul Juntas Morales; François Constant Boyer; Aleksandra Nadaj-Pakleza; Agnès Jacquin-Piques
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

3.  Myalgia in 30 Patients with Suspected Myopathy.

Authors:  Diana Lehmann Urban; Elizabeth Lehmann; Leila Motlagh Scholle; Torsten Kraya
Journal:  Int J Environ Res Public Health       Date:  2020-04-06       Impact factor: 3.390

Review 4.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

5.  Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy.

Authors:  Rosemarie H M J M Kroon; Johanna G Kalf; Bert J M de Swart; Barbara M van der Sluijs; Jeffrey C Glennon; Vered Raz; Baziel G van Engelen; Corinne G C Horlings
Journal:  Neurology       Date:  2021-08-11       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.